(Q28250203)

English

Signaling via ErbB2 and ErbB3 associates with resistance and epidermal growth factor receptor (EGFR) amplification with sensitivity to EGFR inhibitor gefitinib in head and neck squamous cell carcinoma cells

scientific article

Statements

Signaling via ErbB2 and ErbB3 associates with resistance and epidermal growth factor receptor (EGFR) amplification with sensitivity to EGFR inhibitor gefitinib in head and neck squamous cell carcinoma cells (English)
0 references
0 references
Kaisa Erjala
0 references
Maria Sundvall
0 references
Teemu T Junttila
0 references
Na Zhang
0 references
Mika Savisalo
0 references
Pekka Mali
0 references
Jarmo Kulmala
0 references
Jaakko Pulkkinen
0 references
Reidar Grenman
0 references
1 July 2006
0 references
12
0 references
4103-11
0 references
13
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit